TR201716207A2 - Vilanterol ve umeklidinyum içeren farmasötik formülasyonlar. - Google Patents

Vilanterol ve umeklidinyum içeren farmasötik formülasyonlar. Download PDF

Info

Publication number
TR201716207A2
TR201716207A2 TR2017/16207A TR201716207A TR201716207A2 TR 201716207 A2 TR201716207 A2 TR 201716207A2 TR 2017/16207 A TR2017/16207 A TR 2017/16207A TR 201716207 A TR201716207 A TR 201716207A TR 201716207 A2 TR201716207 A2 TR 201716207A2
Authority
TR
Turkey
Prior art keywords
umeclidinium
vilanterol
pharmaceutical formulations
formulations containing
dry powder
Prior art date
Application number
TR2017/16207A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi filed Critical Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/16238A priority Critical patent/TR201716238A1/tr
Publication of TR201716207A2 publication Critical patent/TR201716207A2/tr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Mevcut buluş, solunum yolu rahatsızlıklarında kullanılmak üzere, Vilanterol ve Umeklidinyumdan oluşan, kuru toz formundaki farmasötik formülasyonlara ilişkindir.
TR2017/16207A 2017-10-18 2017-10-20 Vilanterol ve umeklidinyum içeren farmasötik formülasyonlar. TR201716207A2 (tr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2017/16238A TR201716238A1 (tr) 2017-10-18 2017-10-20 Yeni farmasötik bileşimler.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/16203A TR201716203A1 (tr) 2017-10-20 2017-10-20 Yeni umeklidinyum formülasyonları.

Publications (1)

Publication Number Publication Date
TR201716207A2 true TR201716207A2 (tr) 2019-05-21

Family

ID=67954794

Family Applications (3)

Application Number Title Priority Date Filing Date
TR2017/16207A TR201716207A2 (tr) 2017-10-18 2017-10-20 Vilanterol ve umeklidinyum içeren farmasötik formülasyonlar.
TR2017/16203A TR201716203A1 (tr) 2017-09-30 2017-10-20 Yeni umeklidinyum formülasyonları.
TR2017/16209A TR201716209A2 (tr) 2017-09-30 2017-10-20 Arformoterol ve umeklidinyum içeren yeni farmasötik bileşimler.

Family Applications After (2)

Application Number Title Priority Date Filing Date
TR2017/16203A TR201716203A1 (tr) 2017-09-30 2017-10-20 Yeni umeklidinyum formülasyonları.
TR2017/16209A TR201716209A2 (tr) 2017-09-30 2017-10-20 Arformoterol ve umeklidinyum içeren yeni farmasötik bileşimler.

Country Status (1)

Country Link
TR (3) TR201716207A2 (tr)

Also Published As

Publication number Publication date
TR201716203A1 (tr) 2019-05-21
TR201716209A2 (tr) 2019-05-21

Similar Documents

Publication Publication Date Title
CY1125595T1 (el) Σκευασμα ξηρης σκονης που περιλαμβανει ενα κορτικοστεροειδες και ενα βητα-αδρενεργικο για χορηγηση δια εισπνοης
IL263709A (en) Methods for the manufacture of cannabinoid prodrugs, pharmaceutical formulations and their use
HUE061174T2 (hu) 1,3,4-oxadiazol-szulfonamid-származék vegyületek mint hiszton-deacetiláz-6 inhibitorok, és az ilyen vegyületeket tartalmazó gyógyszerkészímény
MX378273B (es) Compuestos activos hacia bromodominios.
DOP2017000306A (es) Formulaciones farmacéuticas que contienen tenofovir y emtricitabina
MX388733B (es) Polvos secos antifungicos.
IL283539A (en) 3,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the same
DK3426294T3 (da) Farmaceutisk formulering omfattende antistof, cyclodextrin og methionin
CY1122473T1 (el) Βελτιστοποιημενο μεσαλαζiνουχο δισκιο υψηλης δοσης
WO2016140933A3 (en) Immediate release soluble ibuprofen compositions
DK3429559T3 (da) Velsmagende sammensætninger indeholdende natriumphenylbutyrat og anvendelser deraf
HUE057871T2 (hu) Gyógyászati hatóanyagokat tartalmazó hialuronán konjugátumok, eljárások és kompozíciók
AR108233A1 (es) Composiciones farmacéuticas orales de nicotinamida
MX393915B (es) Nuevas formulaciones orales de belinostat.
MX390441B (es) Formulaciones liquidas de fosfaplatino.
MX2018009948A (es) Formulaciones de oritavancina.
TR201716207A2 (tr) Vilanterol ve umeklidinyum içeren farmasötik formülasyonlar.
EP3623384A4 (en) ANTI-CLDN-5 ANTIBODY AND ACTIVE SUBSTANCE WITH THIS ANTIBODY
EA201891848A1 (ru) Фармацевтическая композиция для применения в лечении фиброза
LT3097921T (lt) Kompozicijos, apimančios geraniolį ir sausą imbierą, skirtos naudoti dirgliosios žarnos sindromo gydymui
TR201714725A1 (tr) Beta-2 agoni̇sti̇ ve anti̇koli̇nerji̇k i̇çeren kuru toz formülasyonu
TR201714728A1 (tr) Beta-2 Agonist ve Kortikosteroid içeren kuru toz formülasyonu.
TR201714893A1 (tr) Beta-2 Agonisti ve Kortikosteroid içeren kuru toz bileşimi.
LV15003A (lv) Farmaceitiska kompozīcija ķermeņa masas pieauguma kontrolei
EA202091403A1 (ru) Производные 2-оксо-1-пирролидинилимидазотиадиазола